Phase 1 of the CFP Weight Loss Protocol, known as Fat Loading, sets the metabolic foundation for sustainable transformation. Rather than jumping straight into caloric restriction, this preparatory stage strategically increases healthy fat intake while introducing tirzepatide at micro-doses. The goal is to restore leptin sensitivity, reduce systemic inflammation measured by CRP, and prime mitochondria for efficient fat oxidation.
Russell Clark’s clinical approach challenges the outdated CICO model by focusing on hormonal signaling. By addressing GIP and GLP-1 pathways early, patients experience fewer side effects and better long-term adherence during the subsequent 30-Week Tirzepatide Reset.
What Is the Purpose of Phase 1 Fat Loading?
Fat Loading lasts approximately 14–21 days and serves multiple physiological roles. First, it gently elevates dietary fat to downregulate leptin resistance caused by chronic high-sugar intake. When leptin sensitivity returns, the brain once again hears satiety signals, reducing hidden hunger despite nutrient-dense meals.
Second, this phase lowers baseline CRP levels through an anti-inflammatory protocol that eliminates lectins from grains, nightshades, and legumes. Clinical observations show hs-CRP often drops 30–50% before aggressive fat loss begins, indicating the body is shifting from defense to repair mode.
Third, increased fat consumption combined with low-dose tirzepatide teaches the body to rely on lipids for fuel. Early ketone production during this stage signals improved mitochondrial efficiency, setting the stage for Phase 2: Aggressive Loss.
Patients following Clark’s protocol report steadier energy, reduced cravings, and measurable improvements in HOMA-IR even before major weight drops occur. Body composition scans typically reveal visceral fat reduction while lean mass remains stable.
How Does Tirzepatide Work in Phase 1?
Tirzepatide’s dual agonism of GLP-1 and GIP receptors makes it uniquely suited for metabolic reset. In micro-doses during Fat Loading, it slows gastric emptying, enhances insulin secretion only when glucose is elevated, and modulates lipid metabolism via GIP pathways.
Subcutaneous injections are administered weekly, with patients rotating sites to prevent lipohypertrophy. Clark emphasizes starting low—often 0.5–1 mg—to minimize gastrointestinal side effects while still achieving receptor sensitization. This gentle introduction improves tolerability across the full 30-week cycle.
Research supports that GIP co-agonism not only amplifies weight loss beyond GLP-1 alone but may protect against muscle loss. When paired with adequate protein and resistance training, patients preserve BMR despite caloric shifts. This counters the metabolic adaptation that plagues traditional diets.
What Should the Phase 1 Diet Look Like?
The nutritional framework prioritizes nutrient density and lectin avoidance. Core foods include pasture-raised proteins, wild-caught fish, extra-virgin olive oil, avocados, and low-lectin vegetables such as bok choy, broccoli, cauliflower, and zucchini. Berries and limited green apples provide low-glycemic carbohydrates.
Daily fat intake often reaches 60–70% of calories during this loading window, but emphasis remains on quality—fats that support mitochondrial membrane health and reduce oxidative stress. This is not a free-for-all; portion control around nutrient-dense choices prevents overconsumption.
Meal timing matters. Clark recommends earlier dinners to align with circadian rhythms and support overnight fat metabolism. Hydration targets exceed three liters daily, often including electrolytes to offset shifts in fluid balance as inflammation decreases.
Patients track ketones via urine strips or blood meters to confirm the metabolic pivot. The appearance of consistent ketones validates that mitochondria are efficiently converting stored fat into usable energy rather than relying on glucose.
How Does Phase 1 Connect to the Full 70-Day Cycle?
Phase 1 flows directly into the 40-day Aggressive Loss window (Phase 2), where medication dosage increases and carbohydrates are further restricted to deepen ketosis. The final 28 days constitute the Maintenance Phase, during which patients stabilize their new body composition and cement habits that support lifelong metabolic health.
The entire 70-day cycle is designed as a repeatable metabolic reset rather than perpetual medication dependence. By front-loading hormonal repair in Phase 1, subsequent phases produce faster, more sustainable results with less muscle catabolism. Follow-up labs typically show improved HOMA-IR, normalized CRP, and favorable shifts in body composition metrics.
Clark’s approach integrates red light therapy to further enhance mitochondrial function during all phases. Light in the 660–850 nm spectrum supports ATP production and may accelerate fat mobilization from stubborn areas.
Common Questions About Optimizing Phase 1
How much fat is truly needed in Phase 1? Clark suggests calculating 1.5–2 grams per kilogram of ideal body weight initially, then adjusting based on ketone readings and energy levels. The focus is quality over sheer volume.
What if side effects appear? Micro-dosing and the anti-inflammatory diet significantly reduce nausea. Ginger tea, peppermint, and slower dose titration help. Persistent issues warrant medical review of injection technique or concurrent medications.
Can vegetarians follow this protocol? Yes, with careful planning. Eggs, hemp seeds, and select low-lectin plant fats replace animal proteins while maintaining nutrient density. BMR preservation remains the priority through resistance training.
How do I know leptin sensitivity is returning? Improved satiety between meals, reduced nighttime cravings, and stable energy without frequent snacking are clinical hallmarks. Some patients retest leptin levels after 30 days.
Is Phase 1 appropriate for everyone? Most adults with insulin resistance or elevated CRP benefit, but those with gallbladder issues or very low baseline fat intake require modified approaches under clinical supervision.
Practical Steps to Begin Your Fat Loading Phase
- Obtain baseline labs including hs-CRP, fasting insulin, glucose (for HOMA-IR calculation), and body composition analysis.
- Remove all high-lectin foods for the full cycle.
- Increase healthy fats gradually over three days while beginning micro-dose tirzepatide.
- Incorporate daily movement—walking plus two resistance sessions weekly—to protect muscle and BMR.
- Track ketones, energy, and hunger daily. Adjust fat intake if ketones remain low after seven days.
- Schedule follow-up labs at day 21 to confirm inflammatory and metabolic markers are trending favorably.
Successful Phase 1 creates momentum that carries through the entire CFP Weight Loss Protocol. Patients consistently report that investing time in proper metabolic preparation yields deeper fat loss, better muscle retention, and easier maintenance than aggressive dieting ever achieved.
The science is clear: addressing inflammation, restoring incretin signaling through GLP-1 and GIP pathways, and optimizing mitochondrial efficiency before aggressive loss produces superior clinical outcomes. Russell Clark’s structured, phased methodology offers a roadmap grounded in physiology rather than willpower alone.
By understanding and optimizing Fat Loading, individuals can break the cycle of yo-yo dieting and achieve the lasting metabolic transformation they seek.